Medical Oddities: The Calmest Move in Cardiology? - Scorecard - MDSpire

Medical Oddities: The Calmest Move in Cardiology?

Yoga for SVT, romantic brain bias, dog-made air chemistry, math learning clues, selenium tea, and glaucoma pillows—medicine’s weekly roundup of strange.

  • By

  • Teraya Smith

  • March 5, 2026

  • 7 min

Share

Clinical Scorecard: The Calmest Move in Cardiology?

At a Glance

CategoryDetail
ConditionRecurrent Supraventricular Tachycardia (SVT)
Key MechanismsBoosting vagal tone and venous return
Target PopulationIndividuals with recurrent SVT
Care SettingEmergency department

Key Highlights

  • Yoga Child's Pose (Balasana) effectively converted SVT to sinus tachycardia.
  • Patient managed episodes independently without medication.
  • Technique used approximately once a month to control symptoms.

Guideline-Based Recommendations

Diagnosis

  • ECG confirmation of SVT type (e.g., atrioventricular nodal re-entrant tachycardia).

Management

  • Consider non-pharmacological interventions such as vagal maneuvers.

Monitoring & Follow-up

  • Regular monitoring of heart rhythm during episodes.

Risks

  • Potential for recurrent episodes and need for ablation.

Patient & Prescribing Data

Young adults with recurrent SVT.

Yoga poses may serve as effective self-management strategies.

Clinical Best Practices

  • Encourage patients to explore non-invasive techniques for symptom management.
  • Educate patients on the benefits of vagal maneuvers.

Related Resources & Content

Original Source(s)

Medical Oddities: The Calmest Move in Cardiology?

  • by Teraya Smith

  • March 5, 2026

Related Content

Top 10 States for Physician-Owned Hospitals

These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Digitalis Reduces HF Events but Not Mortality

Meta-analysis of randomized trials found fewer worsening heart failure events among patients with reduced or mildly reduced ejection fraction.